These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 555240)

  • 1. [Combination of phosphatidylcholine and pentoxifylline in the therapy of progressive obstructive stroke].
    Tessitore A; Barone A
    Acta Neurol Quad (Napoli); 1979; 39():226-8. PubMed ID: 555240
    [No Abstract]   [Full Text] [Related]  

  • 2. Hemorheologic conditions in patients with cerebrovascular disease altered by treatment with pentoxifylline.
    Ott E; Lechner H
    Ric Clin Lab; 1981; 11 Suppl 1():253-6. PubMed ID: 7188113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Special therapeutical aspects of cerebrovascular disease.
    Lechner H; Ott E
    Ric Clin Lab; 1981; 11 Suppl 1():247-51. PubMed ID: 7188112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on platelet aggregation with pentoxifylline: effect on neoplastic disorders and other new indications.
    Ambrus JL; Ambrus CM; Gastpar H
    J Med; 1979; 10(5):339-45. PubMed ID: 119023
    [No Abstract]   [Full Text] [Related]  

  • 5. Update on the pharmacology of pentoxifylline and its combination with low-dose acetylsalicylic acid (HWA 5112).
    Seiffge D; Weithmann KU
    Semin Thromb Hemost; 1989 Apr; 15(2):150-8. PubMed ID: 2749263
    [No Abstract]   [Full Text] [Related]  

  • 6. Hemorheological effects of pentoxifylline on disturbed flow behavior of blood in patients with cerebrovascular insufficiency.
    Ott E; Lechner H; Fazekas F
    Eur Neurol; 1983; 22 Suppl 1():105-7. PubMed ID: 6884401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Indications for using trental in the initial manifestations of inadequate blood supply to the brain].
    Eninia GI; Egere DA; Robule VKh; Maĭore IKh
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(1):50-2. PubMed ID: 3953193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical evaluation of the effects of pentoxifylline in patients with chronic peripheral circulatory disorders].
    Strano A; Davì G; Novo S; Avellone G; Pinto A
    Ric Clin Lab; 1981; 11 Suppl 1():303-11. PubMed ID: 7188117
    [No Abstract]   [Full Text] [Related]  

  • 9. Hemorheology and peripheral vascular diseases: a new therapeutic approach.
    Müller R
    J Med; 1981; 12(4):209-35. PubMed ID: 7031157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative evaluation of the efficacy of various methods in the treatment of diabetic retinopathies].
    Gol'tseva SV
    Oftalmol Zh; 1983; 38(1):36-8. PubMed ID: 6866402
    [No Abstract]   [Full Text] [Related]  

  • 11. Pentoxifylline -- a biomedical profile.
    Müller R
    J Med; 1979; 10(5):307-29. PubMed ID: 393789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Red cell flexibility and platelet aggregation in patients with chronic obstructive vascular disease (COAD) and study of therapeutic approaches.
    Ambrus JL; Ambrus CM; Taheri SA; Gastpar H; Reddington MM; Taheri P; Kahn EA; Schattman GL; Dean LS; Moore RH
    Angiology; 1984 Jul; 35(7):418-26. PubMed ID: 6540538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Whole blood viscosity in patients with acral arterial occlusive diseases and their modification by rheologically active drugs].
    Runge E; Thiele P
    Z Gesamte Inn Med; 1987 Mar; 42(5):137-41. PubMed ID: 3590891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pentoxifylline and cerebrovascular diseases.
    Marcel GA; George C
    Eur Neurol; 1983; 22 Suppl 1():89-97. PubMed ID: 6350013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of pentoxifylline in the treatment of acute cerebrovascular insufficiency.
    Beyreder J
    Eur Neurol; 1983; 22 Suppl 1():116-23. PubMed ID: 6350007
    [No Abstract]   [Full Text] [Related]  

  • 16. Haemorheological role of platelet aggregation and hypercoagulability in microcirculation: therapeutical approach with pentoxifylline.
    Müller R; Lebrach F
    Pharmatherapeutica; 1980; 2(6):372-9. PubMed ID: 7001492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intermittent claudication treated with pentoxifylline. A controlled trial].
    Skovborg F; Bonde-Petersen F; Bloch I; Christensen E
    Ugeskr Laeger; 1983 Nov; 145(47):3649-52. PubMed ID: 6362159
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapeutic efficacy of pentoxifylline in peripheral artery diseases: its clinical value].
    Benignetti G; Fabbri F; Benvenuti C
    Clin Ter; 1983 Feb; 104(4):297-304. PubMed ID: 6861465
    [No Abstract]   [Full Text] [Related]  

  • 19. [Chronic senile cerebrovascular insufficiency. Effects of suloctidil and pentoxifylline on erythrocyte deformability].
    Pilla G; Ciaponi A; Migliavacca A; Bonora C
    Ric Clin Lab; 1983; 13 Suppl 3():459-64. PubMed ID: 6324325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amelioration of blood viscosity in sickle cell anemia by pentoxifylline. A case report.
    Keller F; Leonhardt H
    J Med; 1979; 10(6):429-33. PubMed ID: 299452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.